MedPath

Docel Docetaxel Injection 10mg/mL

Registration Number: MAL24036036AZ

Approved
Approval ID

0c562d98c7eba423

Registration Number

MAL24036036AZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (3)

80mg/8mL VialsAvailable
Package Size: 80mg/8mL Vials
Status: NPRA Approved
160mg/16mL VialsAvailable
Package Size: 160mg/16mL Vials
Status: NPRA Approved
20mg/2mL VialsAvailable
Package Size: 20mg/2mL Vials
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

DOCETAXEL TRIHYDRATEActive
Monograph: docetaxel trihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Docel Docetaxel Injection 10mg/mL - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform